CuS nanoparticles: clinically favorable materials for photothermal applications?
1MIT-Harvard Center of Cancer Nanotechnology Excellence, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 02139, USA.
Nanomedicine (London, England)
|April 22, 2014
Abstract
No abstract available in PubMed .
More Related Videos
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
1.8K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
2.7K
